Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 4Q Financial Reports: West Pharmaceutical Services, Inc. | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

4Q Financial Reports: West Pharmaceutical Services, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

West Pharmaceutical Services, Inc.

4Q Revenue: $195.6 million (+38%)

4Q Earnings: $12.9 million (+77%)

FY Revenues: $699.7 million (+29%)

FY Earnings: $45.2 million (+35%)

Comments: Pharmaceutical systems business sales grew 9.5% to $136.4 million in the quarter and gross profit in the segment was $44 million, or 32% of sales. Monarch Laboratories, acquired in February 2005, and Medimop Medical Projects, acquired in August 2005, are included in the Pharmaceutical Systems segment. Improvement in the segment’s gross margin was a result of production efficiencies, higher margin products and services in the Monarch Labs and Medimop Medical Projects businesses, and lower workers compensation costs.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters